The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Fatty liver disease, also known as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), is a chronic liver ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

A doctor has shared the warning signs of fatty liver disease you might not initially realise are a sign of a bigger issue. Dr ...

The ability to predict well in advance could allow for early intervention and prevention. Researchers have discovered five ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

Results showed that 62.9% of patients on Ozempic saw a reduction in liver inflammation, compared to 34.3% on placebo.